Official EU label nameGlossary entry 24133
RETINOIC ACID
This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.
Global evidence snapshot
The resolved identity has matching regulatory evidence in 9 of 13 indexed market datasets: 9 country records and 0 EU Annex records. Every result and evidence gap is listed below.
Markets checked
13
Markets with evidence
9
Evidence gaps
4
Resolved identifiers
4
Resolved substance identity
CAS:302-79-44759-48-213497-05-7
EC:206-129-0
Ingredient index records:
RETINOIC ACID
Cosmetic functions: NOT REPORTED
3,7-Dimethyl-9-(2.6.6-Trimethyl-1-Cyclohexen-1-yl)-2,4,6,8-Nonatetraenoic Acid
Inventory restriction note: II/375
8 matched or reported names
RETINOIC ACIDTretinoin (INN) (retinoic acid and its salts)Retinoic Acid and its saltsRetinoic acid (tretinoin (INN)) and its salts维甲酸（视黄酸）及其盐类 — Tretinoin （INN） （retinoic acid） （CAS No. 302-79-4） and its salts트레티노인(레티노익애씨드 및 그 염류)Tretinoína* (ácido retinóico e seus sais)Tretinoin (*) (retinoic acid and its salts) (CAS No. 302-79-4)
Regulatory evidence in all 13 markets
Open each matched record for its scope, concentration, conditions, warnings and official source version.
Swipe or scroll horizontally to see dataset coverage and next actions.
| Market | Result | Records | Dataset | Meaning / next action |
|---|---|---|---|---|
| European Union EU | No local match | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | Prohibited | 1Open record 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | Review every linked record and exact conditions. |
| Canada CA | Prohibited | 1Open record 1 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | Review every linked record and exact conditions. |
| New Zealand NZ | Prohibited | 1Open record 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Review every linked record and exact conditions. |
| ASEAN ASEAN | Prohibited | 1Open record 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Review every linked record and exact conditions. |
| China CN | Prohibited | 1Open record 1 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | Review every linked record and exact conditions. |
| Japan JP | No local match | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Prohibited | 1Open record 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Review every linked record and exact conditions. |
| United States US | No local match | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | No local match | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Prohibited | 1Open record 1 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | Review every linked record and exact conditions. |
| India IN | Prohibited | 1Open record 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | Review every linked record and exact conditions. |
| Saudi Arabia SA | Prohibited | 1Open record 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Review every linked record and exact conditions. |
No market rows match this filter.
Matching market records and conditions
Canada
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026China
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025South Korea
MFDS Notice 2026-19, effective 18 March 2026Brazil
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Chemical identity and properties
CAS 13497-05-7PubChem CID 23665641
Sodium retinoate
- IUPAC name
- sodium (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
- Molecular formula
- C20H27NaO2
- Molecular weight
- 322.4 g/mol
- Exact mass
- 322.19087438 Da
- Topological polar surface area
- 40.1 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 2
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
DD7YX785YARefChem:1098846Retinoic acid sodium saltAll-trans-Retinoic acid sodium saltSodium (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoatesodium;(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoateRetinoic acid, sodium saltVitamin A acid sodium salt
7 more reported names
Retinoic acid, all-trans-, sodium saltRetinoic acid, sodium salt, all-trans-Sodium 15-oxidoretinalall-trans-Retinoic acid sodium salt (1:1)UNII-DD7YX785YAVITAMIN A ACID, SODIUM SALTRETINOIC ACID, SODIUM SALT (1:1)
External database identifiers
- EPA DTXSID:DTXSID50858775
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 302-79-4PubChem CID 444795
Retinoic Acid
All-trans-retinoic acid is a retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry. It has a role as an antioxidant, an antineoplastic agent, a keratolytic drug, a signalling molecule, a retinoid X receptor agonist, an anti-inflammatory agent, a retinoic acid receptor agonist, an AP-1 antagonist and a human metabolite. It is a vitamin A and a retinoic acid. It is a conjugate acid of an all-trans-retinoate. — ChEBI
- IUPAC name
- (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
- Molecular formula
- C20H28O2
- Molecular weight
- 300.4 g/mol
- Exact mass
- 300.208930132 Da
- XLogP3
- 6.3
- Topological polar surface area
- 37.3 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
tretinoinall-trans-Retinoic acidVitamin A acidtrans-Retinoic acidATRAAberelEudynaDermairol
16 more reported names
Renovaall-trans-Vitamin A acidCordes vasRetin ATretin Mall-trans-TretinoinRetionic acidall-trans-Vitamin A1 acidbeta-RaRetin-A MicroVitamin A1 acid, all-trans-beta-Retinoic acidTretinoinaAtralinall-(E)-Retinoic acidAll Trans Retinoic Acid
External database identifiers
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 4759-48-2PubChem CID 5282379
Isotretinoin
Isotretinoin is a retinoic acid that is all-trans-retinoic acid in which the double bond which is alpha,beta- to the carboxy group is isomerised to Z configuration. A synthetic retinoid, it is used for the treatment of severe cases of acne and other skin diseases. It has a role as an antineoplastic agent, a keratolytic drug and a teratogenic agent. It is a conjugate acid of a 13-cis-retinoate. — ChEBI
- IUPAC name
- (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
- Molecular formula
- C20H28O2
- Molecular weight
- 300.4 g/mol
- Exact mass
- 300.208930132 Da
- XLogP3
- 6.3
- Topological polar surface area
- 37.3 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
13-cis-Retinoic acidAccutane13-cis-Vitamin A acidNeovitamin A acidClaravisRoaccutane13-cis retinoic acidAmnesteem
16 more reported names
IsotrexSotretIsotretinoineRoaccutanTeriosalisotretinoinoIsotretinoinumAbsorica13-RARoacutanRETINOIC ACID, 13-cis-Ro-4-3780isotretinoinaMyorisanZenataneRo 4-3780
External database identifiers
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Additional authoritative substance research
Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight
Take this record further
Official source and scope
Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.
Open official Decision